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1078–5884/00Thoracoscopic Sympathectomy for Raynaud’s
Phenomenon—A Long Term Follow-up Study
T.H. Thune,* L. Ladegaard and P.B. LichtDepartment of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, DenmarkObjectives. To assess the long term results of thoracoscopic sympathectomy for Raynaud’s phenomenon.
Design, materials and methods. A retrospective study of 34 consecutive patients who were treated for Raynaud’s
phenomenon by thoracoscopic sympathectomy from 1996 to 2005. Eight patients presented with ulcerations of the digits and
10 had severe ischaemia without ulcerations. The hospital records were retrieved and questionnaires were mailed to the
patients for follow-up.
Results. The questionnaire was answered by 91% of patients after a median follow-up time of 40 months. An immediate
effect was seen in 83% of the patients but symptoms recurred in 60% during the follow-up period. Compensatory sweating
occurred in 63 and 30% reported gustatory sweating. Thirteen patients (43%) regretted having the operation.
Conclusion. The majority of patients with Raynaud’s phenomenon have an excellent immediate effect from thoracoscopic
sympathectomy and one third achieve a long lasting effect. Side effects are frequent. We now only use thoracoscopic
sympathectomy in severe cases of Raynaud’s phenomenon.Keywords: Raynaud’s phenomenon; Sympathectomy; Thoracoscopy.Introduction
Raynaud’s phenomenon is characterized by episodic
digital ischaemia provoked by cold.1 Clinically, it
presents with the classical colour triad sequence of
pallor due to vasospasm, cyanosis from venostasis,
and redness caused by reactive hyperaemia following
the return of blood flow. Raynaud’s phenomenon has
been reviewed extensively in the literature and may be
classified into a primary and a secondary form.1,2
Secondary Raynaud’s phenomenon is mainly seen
in connective tissue disorders and treatment is
directed at the underlying cause. In primary Ray-
naud’s phenomenon, treatment is mostly prophylactic
by avoiding cold exposure or the use of vasospastic
drugs. Medical treatment with calcium-channel block-
ers has also been used.3 In both forms of Raynaud’s
phenomenon the symptoms may progress and digital
ulcerations develop despite conservative or medical
treatment. Thoracoscopic sympathectomy may relieve
symptoms in these patients but there is great
controversy about the efficacy of the operation.ing author. Tom H. Thune, Department of Cardiothor-
scular Surgery, Odense University Hospital, Sdr.
, DK-5000 Odense, Denmark.
: tom@thune.nu
0198 + 05 $35.00/0 q 2006 Elsevier Ltd. All rights reserAlthough the immediate results may be satisfactory,
it is often claimed that long term effects are poor.1,2,4,5
Thus, some investigators discourage the use of
thoracoscopic sympathectomy in patients with Ray-
naud’s phenomenon1,5 and others consider sympath-
ectomy to be the method of choice,6 or at least an
acceptable method for treatment of resistant Ray-
naud’s phenomenon.7–11 This controversy prompted
us to perform a follow-up study in our patients.Materials and Methods
From our databases we identified 35 consecutive
patients who were treated for Raynaud’s phenomenon
by thoracoscopic sympathectomy during a 9-year
period (February 1996–2005). One patient was mis-
classified for angina pectoris and was excluded from
analysis. A total of 408 sympathectomies were
performed during the same period mainly for isolated
or combinations of primary hyperhidrosis and facial
blushing.
All hospital records were retrieved and the following
data recorded: sex, age, diagnostic procedures, length of
hospital stay, uni- or bilateral operation, level ofEur J Vasc Endovasc Surg 32, 198–202 (2006)
doi:10.1016/j.ejvs.2006.01.017, available online at http://www.sciencedirect.com onved.
Raynaud’s Phenomenon 199sympathectomy, duration of the surgical procedure and
any postoperative complications.
Questionnaires were mailed to all patients for
follow-up except for one who had died. All patients
were asked about their symptoms prior to surgery and
if they had a family history of similar symptoms. They
were also asked if they suffered from other diseases
and about their history of tobacco consumption. In
addition, they were asked about their immediate result
from the operation and if their symptoms had
recurred. Further, they were asked to comment on
occurrence and location of any compensatory sweat-
ing defined as excessive sweating after the operation
that was considered abnormal. They were also asked if
they had developed any gustatory sweating defined as
facial sweating when eating certain foods, and if they
had developed any problems with dry hands. Finally,
they were asked if they were satisfied or regretted the
operation.Surgical technique
All patients were operated on by the same surgeon in
the supine position with abduction of both arms under
single-lumen intubated anaesthesia. Throughout the
operation patients were ventilated with 100% inspired
oxygen and anaesthetized with propofol (Diprivanw)
and fentanyl (Haldidw). The procedure was performed
unilaterally or bilaterally depending on the patients
symptoms. Two ports were placed. The first incision
(5-mm) was made anteriorly in the axillary hairline.
The endotracheal tube was briefly disconnected by the
anaesthesiologist to deflate the lung when the pleural
cavity was entered in order to avoid damaging the
lung parenchyma. A 5-mm blunt-tip trocar was
introduced for the use of a 0 or 30-degree video-
thoracoscope (Olympus Winter and Ibe, Hamburg,
Germany). An additional 5-mm trocar was placed
posteriorly in the hairline for the introduction of a
harmonic scalpel (Ultracision, Ethicon Endo Surgery,
Cincinatti, OH, USA). The sympathetic chain was
identified crossing the second, third, and fourth costal
heads. In the first two patients the sympathetic chain
was resected from the lower third of the stellate
ganglion to the third ganglia (T1–T3). In the remaining
patients the parietal pleura was opened and the
sympathectic chain was transected over the second
as well as the third ribs (T2–T3) or the second, third
and fourth ribs (T2–T4). The incision was extended
laterally for approximately 2 cm on the second rib to
include any accessory nerve fibres (the nerve of
Kuntz). In the first nine patients, we routinely left a
chest tube until the next day. In the remaining patientsthe procedure was completed by reinflation of the lung
while the anaesthesiologist ventilated the patient
manually, exerting continuous positive pressure for a
few seconds to prevent pneumothorax, before the
trocar was subsequently removed. The surgical
wounds were closed with Steri-Strip (3M Health
Care, St Paul, MN, USA).Results
Nineteen patients were females (56%) and 15 patients
were males. The median age was 50 years (range 23–82
years). The indication for thoracoscopic sympathec-
tomy was primary Raynaud’s phenomenon in 19
patients. In the remaining 15 patients with secondary
Raynaud’s phenomenon six patients had a working
career with exposure to vibrating tools and the
remaining suffered from connective tissue disorders.
Eight patients presented with ulcerations of their
fingertips and 10 patients had severe ischaemia of
the digits. The median time from the first appearance
of symptoms until sympathectomy was 3 years (range
6 months–40 years). Only eight patients had been
treated with nifedipine and one patient with iloprost,
but none had achieved a satisfactory result. Three
patients had first or second degree relatives with
similar symptoms and 16 patients were smokers
before the operation. All but two patients were seen
by a vascular surgeon prior to surgery. The last two
patients were referred directly from a rheumatologist
with severe secondary Raynaud’s phenomenon. In
addition to their clinical presentation and examination
22 patients (65%) had one or more laboratory
investigations to support the diagnosis, i.e. digital
pressure measurements by strain-gauge before and
after cold exposure and four patients had angiography
of the upper extremity.
Eighteen patients (53%) had bilateral and 16
unilateral operations. A T2–T3 sympathectomy was
the most frequently performed (27 patients), a T2–T4
sympathectomy was used in three patients, and a T1–
T3 sympathectomy in two patients (in the remaining
two patients the level of sympathectomy was not
described in detail in the charts). The median duration
of the surgical procedure was 15 min (range 10–
99 min). There was no peroperative mortality and no
conversion to an open thoracotomy. One patient
developed a pneumothorax, which was treated
conservatively. The median length of the hospital
stay was 2 days (range 1–100 days).
One patient died from lung cancer during the
follow-up period. Of the remaining 33 patients 30
(91%) answered the questionnaire. Two patients didEur J Vasc Endovasc Surg Vol 32, August 2006
Table 1. The immediate effect of the operation and recurrences
Effect of the operation
Excellent Satisfactory Some effect No effect Recurrence
Primary Raynaud 10 (67) 1 (6) 0 (0) 4 (27) 7 (63)
Secondary Raynaud 8 (53) 4 (27) 2 (13) 1 (7) 8 (57)
Total 17 (60) 5 (17) 2 (6) 5 (17) 15 (60)
Number of patients (with percentages in parenthesis).
T. H. Thune et al.200not return the questionnaire despite a reminder and
one patient refused to participate in the follow-up
study without giving a specific reason. The median
follow-up time was 40 months (range 7–114 months).
The immediate effect of the operation and the
recurrence of symptoms are shown in Table 1. In the
eight patients who presented with digital ulceration,
all the ulcers healed. One patient developed a
permanent left sided Horner’s syndrome after a T1–
T3 sympathectomy. Nineteen patients (63%) experi-
enced compensatory sweating which was located on
the abdomen (40%), the back (37%), and/or the thighs
(27%). Nine patients (30%) reported gustatory sweat-
ing and 17 patients (57%) experienced dry hands as a
problem.
During the follow-up period 15 of the 25 patients
who had achieved an effect from the operation (60%)
developed recurrent symptoms after a median time of
5 months (range 2–18 months). Two patients (13%)
described that their recurrent symptoms were more
severe than before sympathectomy, 11 patients (67%)
said that it was the same and in three patients (20%)
their symptoms were milder. Thirteen patients (43%)
regretted the operation and the reasons were lack of
effect of the operation (five patients), compensatory
sweating (one patient), and both in six patients (the
last patient did not give a reason). Of the 18 patients
who presented with digital ulcerations or threatening
digital ischaemia four regretted the procedure (29%)
because symptoms had recurred (three patients) or
because of compensatory sweating (one patient). In
contrast, nine of the 16 patients without digital
ulceration or threatening digital ischaemia (57%)
regretted having the operation because of compensa-
tory sweating (six patients) or because their symptomsTable 2. Previous reports on thoracoscopic sympathectomy for Rayna
Author Year Patients Exte
Nicholson14 1994 30 T2–T
Kresna8 1998 2 Not
Cartier9 1999 10 T2–T
Heuberer et al.7 2000 15 T2–T
DiLorenzo et al.11 2000 4 T2–T
Rajesh13 2002 3 T2–T
Matsumoto et al.6 2002 28 T2–T
Claes5 2003 21
Eur J Vasc Endovasc Surg Vol 32, August 2006had recurred (two patients) and one patient did not
give a reason.Discussion
It has been known for decades that upper thoracic
sympathectomy may relieve symptoms of Raynaud’s
phenomenon12 but this procedure was not performed
routinely because of the invasiveness of a thoracot-
omy. With the introduction of thoracoscopy a minimal
invasive sympathectomy became a surgical option for
patients with Raynaud’s phenomenon. Several studies
have since reported the results of thoracoscopic
sympathectomy for Raynaud’s phenomenon5–11,13,14
and Table 2 demonstrates that most series are small
with short follow-up periods. The term ‘sympathec-
tomy’ is often used synonymously with ‘sympati-
cotomy’ which is the most commonly reported
procedure during which the sympathectic trunk is
divided but not resected. The more complex pro-
cedure of formal excision of the sympathetic chain is
mostly used in North America and may be a reflection
of the medico-legal climate rather than evidence-based
best practice.15 In our institution, we performed
sympathectomy in the first two patients and sympa-
ticotomy in the remaining but like most previous
reports we refer to all procedures as ‘sympathectomy’.
Most papers on sympathectomy for Raynaud’s
phenomenon agree that the immediate effect is
satisfactory. Our results confirm that the majority
(83%) had an immediate effect, which was excellent or
satisfactory in 77%. In patients who presented with
digital ulceration all the ulcers healed. We have no
explanation why five of our patients did not have anyud’s phenomenon
nt of sympathectomy Follow-up Recurrence
3 18 Months 50%
mentioned Not mentioned
3, T2–T4 and T2–T5 28 Months 40%
4 26 Months 13%
5 Not mentioned 0%
4 Not mentioned Not mentioned
4 16 Months 82%
12 Months 100%
Raynaud’s Phenomenon 201effect from the operation. Theoretically, it may be
argued that surgical failures are more likely to occur if
the sympathectic trunk is transected rather than
excised. For example, the sympathectic trunk could
be misinterpretated as the fascia overlying the tendon
of the longus colli muscle. A recent review found a
slightly higher immediate success rate when the
sympathectic trunk was resected.16 However, we
consider transection of the sympathectic chain a
relatively straightforward procedure, and we do not
suspect this to be the reason for our failures because
the same surgeon performed approximately 400
sympathectomies during the study period. Our results
also demonstrate that in the majority their symptoms
recur but in more than one fourth of the patients the
effect may be long lasting. Thus, eight of our patients
(27%) continued to have an effect from the operation
after a median follow-up period of 40 months and in
three patients with recurrence their symptoms were
milder than before sympathectomy. This finding is
positive and contrasts with previous papers. Thus, the
Swedish group in Bora˚s which has one of the highest
volumes of thoracoscopic sympathectomy in the
world claim that recurrence of vascular spasm occurs
in almost all patients within 12 months.4,5
Major complications following thoracoscopic sym-
pathectomy are rare and include Horner’s syndrome,
haemo- and pneumothorax.17 Horner’s syndrome
occurred in one of our patients following a T1–T3
resection where we must have been removed too much
of the stellate ganglion. We have since abandoned this
procedure and only divide the sympathectic chain up to
the T2 level. Compensatory sweating is a common side
effect following sympathectomy for primary hyperhi-
drosis17–19 but only two previous studies have
mentioned it after thoracoscopic sympathectomy for
Raynaud’s phenomenon.6,14 Our results demonstrate
that compensatory sweating occurred in the majority of
our patients (66%) and it was predominately located on
the back and abdomen. The pathophysiology of this side
effect is unknown, but it has long been suggested to be a
thermoregulatory mechanism by which the sweat
glands attempt to compensate for loss of secretory
tissue.20 Gustatory sweating is another well known
although less commonly reported side effect after
sympathectomy for primary hyperhidrosis. It appears
that this side effect has never been reported in patients
after sympathectomy for Raynaud’s phenomenon, but
the present study shows that it is also quite common
(30% of our patients). At present there are no generally
accepted pathophysiological explanations for this
phenomenon. Finally, more than half of our patients
experienced dry hands as a problem. This is caused by
sympathetic denervation of the eccrine sweatglands inthe palm of the hands which are the target for
sympathectomy in patients with primary palmar
hyperhidrosis.
Although the majority of our patients were satisfied
with the operation a substantial proportion (43%)
regretted having a thoracoscopic sympathectomy. In
patients who presented with severe Raynaud’s phenom-
enon the reasons were predominantly lack of effect or
recurrent symptoms and in patients who presented with
milder Raynaud’s phenomenon it was mostly compen-
satory sweating. Our results demonstrate that even
patients who presented with ulceration or severe
ischaemia regretted the procedure (29%). We have no
obvious explanation for this but one may speculate that
with time some patients tend to forget how severe their
primary symptoms were and instead focus on their side
effects or their disappointment with recurrent symp-
toms. Nevertheless, these findings have changed our
daily practice and we emphasize the importance of
patient selection. We discourage patients from surgery if
they present with simple Raynaud’s phenomenon and
only consider sympathectomy if the digits are threa-
tened by digital ulcerations or severe ischaemia despite
medical treatment. In addition, we believe it is very
important to discuss possible complications and side
effects with the patient before surgery. We always inform
patients that compensatory and gustatory sweating and
dry hands are frequent and permanent side effects.
Newer surgical approaches are emerging to try and
reduce the complications of sympathetomy, for
example where the sympathetic trunk is not transected
but clamped endoscopically.21–23 The clamps exert a
force on the sympathetic trunk sufficient enough to
interrupt nerve transmission and in some patients
with intolerable compensatory sweating their side
effect improved from the reverse operation.22,23 To the
best of our knowledge this approach has not been
reported in patients with Raynaud’s phenomenon.
In conclusion, our study shows that the majority of
patients with Raynaud’s phenomenon have an excel-
lent immediate effect from thoracoscopic sympathec-
tomy and one third achieve a long lasting effect.
However, side effects are remarkably frequent and all
patients should be informed thoroughly before sur-
gery. We now discourage the use of thoracoscopic
sympathectomy in patients with simple Raynaud’s
phenomenon and only treat severe cases.References
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